

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.05507172 |
| 2 | protein maturation by protein folding (GO:0022417) | 3.97319678 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 3.78449925 |
| 4 | glycosphingolipid catabolic process (GO:0046479) | 3.68669370 |
| 5 | viral transcription (GO:0019083) | 3.68049809 |
| 6 | pentose-phosphate shunt (GO:0006098) | 3.64838694 |
| 7 | translational termination (GO:0006415) | 3.60059493 |
| 8 | ethanol oxidation (GO:0006069) | 3.57483969 |
| 9 | interferon-gamma secretion (GO:0072643) | 3.55993534 |
| 10 | NADPH regeneration (GO:0006740) | 3.52110821 |
| 11 | pinocytosis (GO:0006907) | 3.42744836 |
| 12 | DNA deamination (GO:0045006) | 3.37119411 |
| 13 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.36240453 |
| 14 | glycolipid catabolic process (GO:0019377) | 3.34400390 |
| 15 | oligosaccharide catabolic process (GO:0009313) | 3.32060364 |
| 16 | translational elongation (GO:0006414) | 3.28109678 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.22681871 |
| 18 | response to thyroid hormone (GO:0097066) | 3.22372467 |
| 19 | hemidesmosome assembly (GO:0031581) | 3.19936729 |
| 20 | ribosomal small subunit biogenesis (GO:0042274) | 3.19025795 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15060229 |
| 22 | protein targeting to ER (GO:0045047) | 3.13663052 |
| 23 | response to peptidoglycan (GO:0032494) | 3.13304036 |
| 24 | maturation of SSU-rRNA (GO:0030490) | 3.13037965 |
| 25 | 4-hydroxyproline metabolic process (GO:0019471) | 3.10520041 |
| 26 | cotranslational protein targeting to membrane (GO:0006613) | 3.10137395 |
| 27 | primary alcohol catabolic process (GO:0034310) | 3.10077160 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 3.09624344 |
| 29 | AMP metabolic process (GO:0046033) | 3.09486178 |
| 30 | formation of translation preinitiation complex (GO:0001731) | 3.07544170 |
| 31 | cellular response to zinc ion (GO:0071294) | 3.07000292 |
| 32 | positive regulation of osteoblast proliferation (GO:0033690) | 3.06901008 |
| 33 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00800742 |
| 34 | ethanol metabolic process (GO:0006067) | 2.98506140 |
| 35 | one-carbon compound transport (GO:0019755) | 2.97528973 |
| 36 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.94705278 |
| 37 | viral life cycle (GO:0019058) | 2.91469737 |
| 38 | translational initiation (GO:0006413) | 2.90685221 |
| 39 | regulation of superoxide anion generation (GO:0032928) | 2.89792075 |
| 40 | L-phenylalanine metabolic process (GO:0006558) | 2.89549098 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.89549098 |
| 42 | ceramide catabolic process (GO:0046514) | 2.88804335 |
| 43 | regulation of mononuclear cell migration (GO:0071675) | 2.87525095 |
| 44 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.86849336 |
| 45 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.86208340 |
| 46 | fibrinolysis (GO:0042730) | 2.84497456 |
| 47 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.82936182 |
| 48 | peptidyl-proline hydroxylation (GO:0019511) | 2.82049214 |
| 49 | cell adhesion mediated by integrin (GO:0033627) | 2.80740973 |
| 50 | purine nucleotide salvage (GO:0032261) | 2.80601652 |
| 51 | proteasome assembly (GO:0043248) | 2.77403149 |
| 52 | hyaluronan catabolic process (GO:0030214) | 2.75416586 |
| 53 | myeloid cell homeostasis (GO:0002262) | 2.74305125 |
| 54 | cyclooxygenase pathway (GO:0019371) | 2.74148285 |
| 55 | cellular response to oxygen radical (GO:0071450) | 2.74041920 |
| 56 | removal of superoxide radicals (GO:0019430) | 2.74041920 |
| 57 | cellular response to superoxide (GO:0071451) | 2.74041920 |
| 58 | aldehyde catabolic process (GO:0046185) | 2.73549485 |
| 59 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73460881 |
| 60 | barbed-end actin filament capping (GO:0051016) | 2.73097921 |
| 61 | cellular protein complex disassembly (GO:0043624) | 2.72882317 |
| 62 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72499351 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 2.71712184 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.71374304 |
| 65 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.70858350 |
| 66 | glucose catabolic process (GO:0006007) | 2.70247241 |
| 67 | regulation of metalloenzyme activity (GO:0048552) | 2.70099862 |
| 68 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.69374183 |
| 69 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.68325755 |
| 70 | ribosomal large subunit biogenesis (GO:0042273) | 2.65890527 |
| 71 | protein autoprocessing (GO:0016540) | 2.65515883 |
| 72 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.64853972 |
| 73 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.64834510 |
| 74 | amino sugar catabolic process (GO:0046348) | 2.64824557 |
| 75 | nitric oxide biosynthetic process (GO:0006809) | 2.64272597 |
| 76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.63891005 |
| 77 | folic acid transport (GO:0015884) | 2.62364594 |
| 78 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.60939750 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.57795508 |
| 80 | sulfur amino acid catabolic process (GO:0000098) | 2.57492604 |
| 81 | protein retention in ER lumen (GO:0006621) | 2.57288099 |
| 82 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.55273641 |
| 83 | immunoglobulin mediated immune response (GO:0016064) | 2.55117615 |
| 84 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.52543060 |
| 85 | retinoic acid metabolic process (GO:0042573) | 2.52017369 |
| 86 | diterpenoid biosynthetic process (GO:0016102) | 2.51334958 |
| 87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.50904009 |
| 88 | heme metabolic process (GO:0042168) | 2.50259381 |
| 89 | regulation of natural killer cell differentiation (GO:0032823) | 2.50235335 |
| 90 | cellular aldehyde metabolic process (GO:0006081) | 2.50231801 |
| 91 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.49172388 |
| 92 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.49172388 |
| 93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.47707051 |
| 94 | L-phenylalanine catabolic process (GO:0006559) | 2.47707051 |
| 95 | galactose catabolic process (GO:0019388) | 2.47380913 |
| 96 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.47100949 |
| 97 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.46722537 |
| 98 | Golgi transport vesicle coating (GO:0048200) | 2.45938405 |
| 99 | COPI coating of Golgi vesicle (GO:0048205) | 2.45938405 |
| 100 | flavonoid metabolic process (GO:0009812) | 2.45701017 |
| 101 | nucleoside salvage (GO:0043174) | 2.45157018 |
| 102 | chondrocyte proliferation (GO:0035988) | 2.45123975 |
| 103 | low-density lipoprotein particle clearance (GO:0034383) | 2.44623579 |
| 104 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.44141221 |
| 105 | NADP metabolic process (GO:0006739) | 2.42664932 |
| 106 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.42133063 |
| 107 | negative regulation of mitochondrion organization (GO:0010823) | 2.41982758 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.40981156 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.40981156 |
| 110 | membrane lipid catabolic process (GO:0046466) | 2.39314723 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39222271 |
| 112 | fibril organization (GO:0097435) | 2.39130181 |
| 113 | T cell apoptotic process (GO:0070231) | 2.38846357 |
| 114 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.38611577 |
| 115 | hepatocyte differentiation (GO:0070365) | 2.38561729 |
| 116 | vitamin A metabolic process (GO:0006776) | 2.38530733 |
| 117 | response to nitrosative stress (GO:0051409) | 2.38395757 |
| 118 | regulation of protein heterodimerization activity (GO:0043497) | 2.38294586 |
| 119 | sphingolipid catabolic process (GO:0030149) | 2.37994218 |
| 120 | regulation of interleukin-8 secretion (GO:2000482) | 2.37977127 |
| 121 | purine-containing compound salvage (GO:0043101) | 2.37619556 |
| 122 | retinal metabolic process (GO:0042574) | 2.37389960 |
| 123 | eosinophil chemotaxis (GO:0048245) | 2.37324947 |
| 124 | lipoxygenase pathway (GO:0019372) | 2.36983426 |
| 125 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.36856251 |
| 126 | regulation of proton transport (GO:0010155) | 2.36389929 |
| 127 | response to interferon-beta (GO:0035456) | 2.36136933 |
| 128 | protein targeting to membrane (GO:0006612) | 2.35636082 |
| 129 | extracellular fibril organization (GO:0043206) | 2.35189697 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.34289536 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.33591491 |
| 132 | translation (GO:0006412) | 2.32790634 |
| 133 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.32435184 |
| 134 | * glutathione derivative metabolic process (GO:1901685) | 2.30628824 |
| 135 | * glutathione derivative biosynthetic process (GO:1901687) | 2.30628824 |
| 136 | protein hydroxylation (GO:0018126) | 2.30570792 |
| 137 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.30465499 |
| 138 | pentose metabolic process (GO:0019321) | 2.30118627 |
| 139 | protein localization to endosome (GO:0036010) | 2.29800925 |
| 140 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.29519994 |
| 141 | negative regulation of fibrinolysis (GO:0051918) | 2.28825024 |
| 142 | epoxygenase P450 pathway (GO:0019373) | 2.28417114 |
| 143 | cellular response to cadmium ion (GO:0071276) | 2.28040945 |
| 144 | defense response to fungus (GO:0050832) | 2.27797989 |
| 145 | folic acid metabolic process (GO:0046655) | 2.27340044 |
| 146 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.27060859 |
| 147 | regulation of vitamin metabolic process (GO:0030656) | 2.26998771 |
| 148 | cysteine metabolic process (GO:0006534) | 2.26985488 |
| 149 | nucleotide salvage (GO:0043173) | 2.26749659 |
| 150 | peptide catabolic process (GO:0043171) | 2.26234143 |
| 151 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.25907755 |
| 152 | regulation of chemokine biosynthetic process (GO:0045073) | 2.25804612 |
| 153 | wound healing, spreading of epidermal cells (GO:0035313) | 2.25445646 |
| 154 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.22175487 |
| 155 | negative regulation of ligase activity (GO:0051352) | 2.22175487 |
| 156 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.21952405 |
| 157 | hydrogen peroxide catabolic process (GO:0042744) | 2.21793689 |
| 158 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.21674729 |
| 159 | protein complex disassembly (GO:0043241) | 2.21662786 |
| 160 | type B pancreatic cell proliferation (GO:0044342) | 2.21642596 |
| 161 | pyrimidine nucleoside salvage (GO:0043097) | 2.21552705 |
| 162 | pyrimidine-containing compound salvage (GO:0008655) | 2.21552705 |
| 163 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.21453795 |
| 164 | carnitine metabolic process (GO:0009437) | 2.20974059 |
| 165 | lymphocyte apoptotic process (GO:0070227) | 2.20574906 |
| 166 | regulation of mitochondrial membrane potential (GO:0051881) | 2.20449010 |
| 167 | glycoside metabolic process (GO:0016137) | 2.20293180 |
| 168 | heme biosynthetic process (GO:0006783) | 2.20195497 |
| 169 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.19993935 |
| 170 | mature B cell differentiation involved in immune response (GO:0002313) | 2.19930061 |
| 171 | regulation of superoxide metabolic process (GO:0090322) | 2.19095420 |
| 172 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.18518181 |
| 173 | phagocytosis, engulfment (GO:0006911) | 2.17712203 |
| 174 | phospholipid efflux (GO:0033700) | 2.15948895 |
| 175 | GDP-mannose metabolic process (GO:0019673) | 2.15358889 |
| 176 | regulation of monocyte chemotaxis (GO:0090025) | 2.14546663 |
| 177 | negative regulation of coagulation (GO:0050819) | 2.13646467 |
| 178 | platelet degranulation (GO:0002576) | 2.13216809 |
| 179 | phagosome maturation (GO:0090382) | 2.13141727 |
| 180 | low-density lipoprotein particle remodeling (GO:0034374) | 2.12779354 |
| 181 | B cell mediated immunity (GO:0019724) | 2.12752193 |
| 182 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.12521863 |
| 183 | autophagic vacuole fusion (GO:0000046) | 2.11837379 |
| 184 | lipopolysaccharide metabolic process (GO:0008653) | 2.11392909 |
| 185 | macrophage differentiation (GO:0030225) | 2.11123337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.45033303 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.89349483 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47001535 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.43944966 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.32279399 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.25561193 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.92380879 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.87745584 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.75782692 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.66974605 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49109395 |
| 12 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.47621985 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.04183482 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03881211 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.96998138 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89229990 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82022077 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80424361 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.76041868 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74632755 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74348004 |
| 22 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.73655949 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72928377 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71989709 |
| 25 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71225990 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69590115 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69043590 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.65789378 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65210286 |
| 30 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64907643 |
| 31 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.64318348 |
| 32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63937331 |
| 33 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.61003938 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58225686 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58224076 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57891344 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57194737 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56041845 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54324584 |
| 40 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53910959 |
| 41 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53402594 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53402594 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52258213 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52003404 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51261897 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49560784 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48797600 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46704809 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45591348 |
| 50 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45448848 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45140590 |
| 52 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44371898 |
| 53 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.41897536 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40898827 |
| 55 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40021131 |
| 56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.39930171 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.39773946 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39517060 |
| 59 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.38710016 |
| 60 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.37433232 |
| 61 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36098580 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34919806 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34902244 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33826813 |
| 65 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33795530 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30009826 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28196224 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28054034 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27844394 |
| 70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27714050 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27586675 |
| 72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27470126 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27178510 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27010504 |
| 75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.27001598 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26183637 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25335270 |
| 78 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25126557 |
| 79 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24575340 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23743742 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23237431 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22497703 |
| 83 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22486569 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21766161 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20845268 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20658339 |
| 87 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19344541 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18587052 |
| 89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18452722 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18321525 |
| 91 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16820592 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16551709 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16348761 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16077628 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15969891 |
| 96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15766126 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14130704 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13677991 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12806730 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11375703 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11361952 |
| 102 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11014711 |
| 103 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.10981553 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09599448 |
| 105 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08657096 |
| 106 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08446751 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08285906 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08058496 |
| 109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08007123 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06743775 |
| 111 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06264140 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06191560 |
| 113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05597545 |
| 114 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05380621 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04706584 |
| 116 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03673444 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02636679 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02128431 |
| 119 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01945059 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01516518 |
| 121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00191138 |
| 122 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99701822 |
| 123 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99653011 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99580723 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99102417 |
| 126 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99033542 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98845844 |
| 128 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.98725375 |
| 129 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98002758 |
| 130 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96830067 |
| 131 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96188073 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.96095758 |
| 133 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94312952 |
| 134 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94038298 |
| 135 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94035897 |
| 136 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.93958910 |
| 137 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93716008 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93531448 |
| 139 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93399891 |
| 140 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92711303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.32442497 |
| 2 | MP0008004_abnormal_stomach_pH | 3.15465298 |
| 3 | MP0003186_abnormal_redox_activity | 2.70954893 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 2.70133223 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.61763202 |
| 6 | MP0006082_CNS_inflammation | 2.38243941 |
| 7 | MP0003303_peritoneal_inflammation | 2.37153060 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.33176947 |
| 9 | MP0006054_spinal_hemorrhage | 2.32784517 |
| 10 | MP0005360_urolithiasis | 2.25918023 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.16994928 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.12995704 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.10848451 |
| 14 | MP0005083_abnormal_biliary_tract | 2.08053373 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.06464683 |
| 16 | MP0005451_abnormal_body_composition | 2.05211084 |
| 17 | MP0003075_altered_response_to | 2.00024636 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.93105662 |
| 19 | MP0009840_abnormal_foam_cell | 1.88074457 |
| 20 | MP0004510_myositis | 1.86032894 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.80779467 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 1.75352109 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.72508590 |
| 24 | MP0008260_abnormal_autophagy | 1.72355858 |
| 25 | MP0005023_abnormal_wound_healing | 1.70962349 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.70203785 |
| 27 | MP0009379_abnormal_foot_pigmentation | 1.67621217 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.65332824 |
| 29 | MP0005365_abnormal_bile_salt | 1.63487795 |
| 30 | MP0000604_amyloidosis | 1.59829857 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.59524405 |
| 32 | MP0000490_abnormal_crypts_of | 1.56738987 |
| 33 | MP0005275_abnormal_skin_tensile | 1.54282920 |
| 34 | MP0009384_cardiac_valve_regurgitation | 1.47900956 |
| 35 | MP0001790_abnormal_immune_system | 1.40381571 |
| 36 | MP0005387_immune_system_phenotype | 1.40381571 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.39110133 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.38485844 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.38094010 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.37728313 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.35441301 |
| 42 | MP0003436_decreased_susceptibility_to | 1.35403785 |
| 43 | MP0001873_stomach_inflammation | 1.34937106 |
| 44 | MP0003011_delayed_dark_adaptation | 1.34006234 |
| 45 | MP0000372_irregular_coat_pigmentation | 1.33533354 |
| 46 | MP0009785_altered_susceptibility_to | 1.31735666 |
| 47 | MP0000858_altered_metastatic_potential | 1.31491319 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.30256817 |
| 49 | MP0005671_abnormal_response_to | 1.30016998 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.29074566 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.29074566 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.28940012 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.28110815 |
| 54 | MP0005166_decreased_susceptibility_to | 1.27937889 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.27005497 |
| 56 | MP0002723_abnormal_immune_serum | 1.26677963 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.25567300 |
| 58 | MP0002060_abnormal_skin_morphology | 1.25162920 |
| 59 | MP0001853_heart_inflammation | 1.24964577 |
| 60 | MP0001958_emphysema | 1.23808653 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.22970373 |
| 62 | MP0002254_reproductive_system_inflammat | 1.22474903 |
| 63 | MP0009697_abnormal_copulation | 1.20912893 |
| 64 | MP0003448_altered_tumor_morphology | 1.20148239 |
| 65 | MP0010368_abnormal_lymphatic_system | 1.17269292 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.16085964 |
| 67 | MP0005408_hypopigmentation | 1.13840352 |
| 68 | MP0002420_abnormal_adaptive_immunity | 1.11693119 |
| 69 | MP0001819_abnormal_immune_cell | 1.11335729 |
| 70 | MP0003279_aneurysm | 1.10384217 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 1.10073558 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 1.09747471 |
| 73 | MP0009763_increased_sensitivity_to | 1.09345703 |
| 74 | MP0009053_abnormal_anal_canal | 1.06566438 |
| 75 | MP0010329_abnormal_lipoprotein_level | 1.03879872 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.00418824 |
| 77 | MP0010030_abnormal_orbit_morphology | 1.00055511 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 0.99537373 |
| 79 | MP0004947_skin_inflammation | 0.99501700 |
| 80 | MP0002132_abnormal_respiratory_system | 0.98282634 |
| 81 | MP0000343_altered_response_to | 0.98086749 |
| 82 | MP0004272_abnormal_basement_membrane | 0.97342522 |
| 83 | MP0000477_abnormal_intestine_morphology | 0.97023405 |
| 84 | MP0003195_calcinosis | 0.96950069 |
| 85 | MP0001800_abnormal_humoral_immune | 0.96722459 |
| 86 | MP0001243_abnormal_dermal_layer | 0.94802754 |
| 87 | MP0002405_respiratory_system_inflammati | 0.93688926 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.93410709 |
| 89 | MP0000358_abnormal_cell_content/ | 0.93148043 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.92437433 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.91858868 |
| 92 | MP0009278_abnormal_bone_marrow | 0.90736156 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.89063109 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.88536223 |
| 95 | MP0000685_abnormal_immune_system | 0.88387826 |
| 96 | MP0002419_abnormal_innate_immunity | 0.88138999 |
| 97 | MP0005165_increased_susceptibility_to | 0.88105037 |
| 98 | MP0000609_abnormal_liver_physiology | 0.87827307 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.87819269 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.87453761 |
| 101 | MP0002796_impaired_skin_barrier | 0.87374648 |
| 102 | MP0005025_abnormal_response_to | 0.87328958 |
| 103 | MP0000467_abnormal_esophagus_morphology | 0.87270041 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.86723443 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.86483308 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.86306517 |
| 107 | MP0000470_abnormal_stomach_morphology | 0.86277922 |
| 108 | MP0000598_abnormal_liver_morphology | 0.85602524 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.85227930 |
| 110 | MP0009764_decreased_sensitivity_to | 0.85218453 |
| 111 | MP0005501_abnormal_skin_physiology | 0.84873623 |
| 112 | MP0005164_abnormal_response_to | 0.84297849 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 0.83881262 |
| 114 | MP0005266_abnormal_metabolism | 0.82839634 |
| 115 | MP0002429_abnormal_blood_cell | 0.81780489 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.81417824 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.81307022 |
| 118 | MP0001663_abnormal_digestive_system | 0.79307429 |
| 119 | MP0001542_abnormal_bone_strength | 0.78624128 |
| 120 | MP0000716_abnormal_immune_system | 0.78268084 |
| 121 | MP0003252_abnormal_bile_duct | 0.77919807 |
| 122 | MP0008469_abnormal_protein_level | 0.77614929 |
| 123 | MP0001849_ear_inflammation | 0.75843161 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.75786274 |
| 125 | MP0005332_abnormal_amino_acid | 0.75464337 |
| 126 | MP0003795_abnormal_bone_structure | 0.75368935 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.74367484 |
| 128 | MP0002295_abnormal_pulmonary_circulatio | 0.74118990 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.73882083 |
| 130 | MP0003941_abnormal_skin_development | 0.73303811 |
| 131 | MP0000627_abnormal_mammary_gland | 0.73260707 |
| 132 | MP0000371_diluted_coat_color | 0.73062553 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.72949904 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72561082 |
| 135 | MP0003091_abnormal_cell_migration | 0.72474558 |
| 136 | MP0002398_abnormal_bone_marrow | 0.71930582 |
| 137 | MP0000249_abnormal_blood_vessel | 0.71639425 |
| 138 | MP0003828_pulmonary_edema | 0.70661778 |
| 139 | MP0003724_increased_susceptibility_to | 0.70134304 |
| 140 | MP0004808_abnormal_hematopoietic_stem | 0.69884716 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.69879599 |
| 142 | MP0000689_abnormal_spleen_morphology | 0.69176251 |
| 143 | MP0005390_skeleton_phenotype | 0.68914836 |
| 144 | MP0005330_cardiomyopathy | 0.68900091 |
| 145 | MP0002090_abnormal_vision | 0.67329624 |
| 146 | MP0001764_abnormal_homeostasis | 0.66993811 |
| 147 | MP0002722_abnormal_immune_system | 0.66625153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.48190576 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.48190576 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.48190576 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.08596161 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.96202528 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.87561427 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 3.80428839 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.74417716 |
| 9 | Purpura (HP:0000979) | 3.59468792 |
| 10 | Premature rupture of membranes (HP:0001788) | 3.52838047 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.45106196 |
| 12 | Atrophic scars (HP:0001075) | 3.43047605 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.42812700 |
| 14 | Abnormal hemoglobin (HP:0011902) | 3.42326382 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.37222271 |
| 16 | Pustule (HP:0200039) | 3.31032649 |
| 17 | Ileus (HP:0002595) | 3.28361383 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.26188078 |
| 19 | Myocardial infarction (HP:0001658) | 3.04785623 |
| 20 | Hepatosplenomegaly (HP:0001433) | 3.01627786 |
| 21 | Loss of speech (HP:0002371) | 2.95232104 |
| 22 | Peritonitis (HP:0002586) | 2.86617774 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.82557944 |
| 24 | Multiple enchondromatosis (HP:0005701) | 2.80375458 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80068562 |
| 26 | Amyloidosis (HP:0011034) | 2.79422422 |
| 27 | Axonal loss (HP:0003447) | 2.77276787 |
| 28 | Thrombocytosis (HP:0001894) | 2.74573827 |
| 29 | Abnormal gallbladder physiology (HP:0012438) | 2.73067580 |
| 30 | Cholecystitis (HP:0001082) | 2.73067580 |
| 31 | Trismus (HP:0000211) | 2.68299861 |
| 32 | Onycholysis (HP:0001806) | 2.62249058 |
| 33 | Oral leukoplakia (HP:0002745) | 2.62161170 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.59250119 |
| 35 | Progressive neurologic deterioration (HP:0002344) | 2.57438271 |
| 36 | Cervical subluxation (HP:0003308) | 2.56820972 |
| 37 | Fragile skin (HP:0001030) | 2.52313032 |
| 38 | Prolonged neonatal jaundice (HP:0006579) | 2.45428125 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44886794 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44886794 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44886794 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.44151365 |
| 43 | Beaking of vertebral bodies (HP:0004568) | 2.43989234 |
| 44 | Abnormal platelet function (HP:0011869) | 2.43859422 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.43859422 |
| 46 | Epistaxis (HP:0000421) | 2.43290316 |
| 47 | Abnormal cartilage morphology (HP:0002763) | 2.40608957 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.39722748 |
| 49 | Nuclear cataract (HP:0100018) | 2.37630419 |
| 50 | Polycythemia (HP:0001901) | 2.35688468 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34724382 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.34724382 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.33455246 |
| 54 | Gastrointestinal dysmotility (HP:0002579) | 2.33335293 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.32477833 |
| 56 | Osteolytic defects of the hand bones (HP:0009699) | 2.32423198 |
| 57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32423198 |
| 58 | Acute necrotizing encephalopathy (HP:0006965) | 2.28680701 |
| 59 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28299332 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.27171086 |
| 61 | Increased serum ferritin (HP:0003281) | 2.26678382 |
| 62 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.25257052 |
| 63 | Fragile nails (HP:0001808) | 2.24958711 |
| 64 | Macrocytic anemia (HP:0001972) | 2.24006805 |
| 65 | Complement deficiency (HP:0004431) | 2.23894398 |
| 66 | Menorrhagia (HP:0000132) | 2.23204555 |
| 67 | Xanthomatosis (HP:0000991) | 2.22772134 |
| 68 | Acute encephalopathy (HP:0006846) | 2.21971632 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.20482005 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.20458529 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.20406964 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.20249356 |
| 73 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.19711866 |
| 74 | Abnormality of complement system (HP:0005339) | 2.19496647 |
| 75 | Aplastic anemia (HP:0001915) | 2.19483277 |
| 76 | Glomerulonephritis (HP:0000099) | 2.18953979 |
| 77 | Microretrognathia (HP:0000308) | 2.18053994 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17702865 |
| 79 | Obstructive lung disease (HP:0006536) | 2.17702865 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.17681955 |
| 81 | Aortic aneurysm (HP:0004942) | 2.17169327 |
| 82 | Gingival bleeding (HP:0000225) | 2.16659048 |
| 83 | Aortic dissection (HP:0002647) | 2.14331739 |
| 84 | Increased connective tissue (HP:0009025) | 2.13849064 |
| 85 | Tetraparesis (HP:0002273) | 2.13360447 |
| 86 | Hypobetalipoproteinemia (HP:0003563) | 2.12340000 |
| 87 | Mitochondrial inheritance (HP:0001427) | 2.11169244 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.10493598 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10452218 |
| 90 | Hyperammonemia (HP:0001987) | 2.09669930 |
| 91 | Reticulocytopenia (HP:0001896) | 2.09121927 |
| 92 | Upper motor neuron abnormality (HP:0002127) | 2.08613670 |
| 93 | Eczematoid dermatitis (HP:0000976) | 2.08610724 |
| 94 | Increased serum pyruvate (HP:0003542) | 2.07939808 |
| 95 | Disinhibition (HP:0000734) | 2.05752223 |
| 96 | Milia (HP:0001056) | 2.04988761 |
| 97 | Short nail (HP:0001799) | 2.03179327 |
| 98 | Hepatocellular necrosis (HP:0001404) | 2.02715870 |
| 99 | Abnormality of glycolysis (HP:0004366) | 2.02169576 |
| 100 | Abnormal blistering of the skin (HP:0008066) | 2.01371828 |
| 101 | Petechiae (HP:0000967) | 2.01282154 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99680041 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 1.98576152 |
| 104 | Orthostatic hypotension (HP:0001278) | 1.98424374 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.98119929 |
| 106 | Alopecia of scalp (HP:0002293) | 1.97987547 |
| 107 | Hepatic necrosis (HP:0002605) | 1.97621083 |
| 108 | Pallor (HP:0000980) | 1.94288020 |
| 109 | Paralysis (HP:0003470) | 1.92661831 |
| 110 | Increased CSF lactate (HP:0002490) | 1.92433750 |
| 111 | Spastic diplegia (HP:0001264) | 1.92022379 |
| 112 | Palpitations (HP:0001962) | 1.91965976 |
| 113 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91551327 |
| 114 | Conjunctival telangiectasia (HP:0000524) | 1.89171466 |
| 115 | Abnormal platelet volume (HP:0011876) | 1.89134685 |
| 116 | Esophageal neoplasm (HP:0100751) | 1.88589325 |
| 117 | Neoplasm of head and neck (HP:0012288) | 1.88589325 |
| 118 | Abnormality of the acetabulum (HP:0003170) | 1.87954718 |
| 119 | Bowed forearm bones (HP:0003956) | 1.87716828 |
| 120 | Bowing of the arm (HP:0006488) | 1.87716828 |
| 121 | Megaloblastic anemia (HP:0001889) | 1.87082507 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86846584 |
| 123 | Hypertensive crisis (HP:0100735) | 1.85972308 |
| 124 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.85492339 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.84691894 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 1.84691894 |
| 127 | Exertional dyspnea (HP:0002875) | 1.84445786 |
| 128 | Rough bone trabeculation (HP:0100670) | 1.84366860 |
| 129 | Nonimmune hydrops fetalis (HP:0001790) | 1.83313701 |
| 130 | Micronodular cirrhosis (HP:0001413) | 1.82972158 |
| 131 | Flat acetabular roof (HP:0003180) | 1.82649573 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.81717154 |
| 133 | Hypolipoproteinemia (HP:0010981) | 1.81606586 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.81412061 |
| 135 | Nail dystrophy (HP:0008404) | 1.81229581 |
| 136 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80842180 |
| 137 | Deep venous thrombosis (HP:0002625) | 1.80794651 |
| 138 | Mucosal telangiectasiae (HP:0100579) | 1.80394690 |
| 139 | Cardiovascular calcification (HP:0011915) | 1.79935935 |
| 140 | Mutism (HP:0002300) | 1.79270744 |
| 141 | Dilatation of the ascending aorta (HP:0005111) | 1.78799088 |
| 142 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78514611 |
| 143 | Abnormal trabecular bone morphology (HP:0100671) | 1.78086423 |
| 144 | Abnormality of the nasal mucosa (HP:0000433) | 1.78055789 |
| 145 | Ulnar bowing (HP:0003031) | 1.77873115 |
| 146 | Spinal rigidity (HP:0003306) | 1.77343497 |
| 147 | Difficulty climbing stairs (HP:0003551) | 1.76952159 |
| 148 | Multiple lipomas (HP:0001012) | 1.76155562 |
| 149 | Rhabdomyolysis (HP:0003201) | 1.75899081 |
| 150 | Dicarboxylic aciduria (HP:0003215) | 1.75286935 |
| 151 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75286935 |
| 152 | Ragged-red muscle fibers (HP:0003200) | 1.74988675 |
| 153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74556734 |
| 154 | Respiratory failure (HP:0002878) | 1.74040016 |
| 155 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.73583483 |
| 156 | Ventricular tachycardia (HP:0004756) | 1.73498360 |
| 157 | Biconcave vertebral bodies (HP:0004586) | 1.73409796 |
| 158 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.73342365 |
| 159 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.73342365 |
| 160 | Cerebral edema (HP:0002181) | 1.72596663 |
| 161 | Gout (HP:0001997) | 1.72009567 |
| 162 | Abnormality of the umbilical cord (HP:0010881) | 1.71692325 |
| 163 | Nausea (HP:0002018) | 1.70717644 |
| 164 | Esophageal varix (HP:0002040) | 1.69981535 |
| 165 | Congenital, generalized hypertrichosis (HP:0004540) | 1.69706836 |
| 166 | Mediastinal lymphadenopathy (HP:0100721) | 1.69631523 |
| 167 | Vascular calcification (HP:0004934) | 1.69616067 |
| 168 | Increased IgM level (HP:0003496) | 1.69445891 |
| 169 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69161690 |
| 170 | Cerebral aneurysm (HP:0004944) | 1.68784883 |
| 171 | Ankle contracture (HP:0006466) | 1.68391049 |
| 172 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68297372 |
| 173 | Abnormality of the intrinsic pathway (HP:0010989) | 1.67679053 |
| 174 | Increased mean platelet volume (HP:0011877) | 1.67037173 |
| 175 | Hoarse voice (HP:0001609) | 1.66692831 |
| 176 | Hypoglycemic coma (HP:0001325) | 1.66030248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.47030640 |
| 2 | NME2 | 3.65417599 |
| 3 | PIM2 | 3.56702487 |
| 4 | TESK1 | 2.97545217 |
| 5 | TESK2 | 2.29066624 |
| 6 | TRIB3 | 2.25190956 |
| 7 | MST1R | 2.16640076 |
| 8 | PDK2 | 2.09326607 |
| 9 | PKN2 | 2.05659863 |
| 10 | MAP3K12 | 2.05178005 |
| 11 | TRPM7 | 1.97182929 |
| 12 | ERN1 | 1.93529783 |
| 13 | LRRK2 | 1.93141892 |
| 14 | MST4 | 1.92949464 |
| 15 | LIMK1 | 1.86076701 |
| 16 | MAP3K3 | 1.82056730 |
| 17 | MAP3K11 | 1.78372913 |
| 18 | MAPKAPK3 | 1.74152920 |
| 19 | VRK2 | 1.68127635 |
| 20 | RPS6KB2 | 1.62725168 |
| 21 | PAK4 | 1.62334137 |
| 22 | ERBB3 | 1.58047556 |
| 23 | KDR | 1.55405300 |
| 24 | TTN | 1.55095030 |
| 25 | BMPR2 | 1.54468347 |
| 26 | GRK7 | 1.54332470 |
| 27 | EIF2AK1 | 1.53416995 |
| 28 | MAP2K3 | 1.45079852 |
| 29 | SCYL2 | 1.43786161 |
| 30 | MYLK | 1.43706439 |
| 31 | FLT3 | 1.42963528 |
| 32 | RPS6KA4 | 1.38547953 |
| 33 | RIPK4 | 1.38506523 |
| 34 | TBK1 | 1.37160831 |
| 35 | BCKDK | 1.37070877 |
| 36 | PIK3CG | 1.25293631 |
| 37 | WEE1 | 1.21585687 |
| 38 | MAP3K14 | 1.19899462 |
| 39 | BUB1 | 1.19063097 |
| 40 | EIF2AK3 | 1.13530308 |
| 41 | STK10 | 1.13386167 |
| 42 | ZAP70 | 1.11492134 |
| 43 | TAOK2 | 1.10839589 |
| 44 | MAP3K8 | 1.09316732 |
| 45 | EEF2K | 1.09039014 |
| 46 | NEK9 | 1.08017943 |
| 47 | DAPK1 | 1.06494777 |
| 48 | PRKG2 | 1.04410870 |
| 49 | PTK6 | 1.04188652 |
| 50 | ABL2 | 1.03871506 |
| 51 | PTK2 | 1.02059077 |
| 52 | TGFBR1 | 1.00960474 |
| 53 | IRAK3 | 0.98475668 |
| 54 | EPHB2 | 0.97424243 |
| 55 | NEK1 | 0.96713894 |
| 56 | MET | 0.92825140 |
| 57 | PAK2 | 0.92472351 |
| 58 | DDR2 | 0.91369460 |
| 59 | PBK | 0.89550066 |
| 60 | LMTK2 | 0.86079714 |
| 61 | ERBB4 | 0.85945593 |
| 62 | DYRK3 | 0.85812998 |
| 63 | MAP2K2 | 0.83165634 |
| 64 | NME1 | 0.82628939 |
| 65 | FER | 0.81575596 |
| 66 | FRK | 0.80385284 |
| 67 | ILK | 0.80104007 |
| 68 | BRAF | 0.75902824 |
| 69 | STK16 | 0.75271739 |
| 70 | ACVR1B | 0.74464068 |
| 71 | PIK3CA | 0.72971519 |
| 72 | DAPK3 | 0.71982906 |
| 73 | FGR | 0.71420445 |
| 74 | CLK1 | 0.70726604 |
| 75 | MAP2K1 | 0.70301030 |
| 76 | PRPF4B | 0.70257136 |
| 77 | MAP3K5 | 0.70169739 |
| 78 | BMX | 0.70167160 |
| 79 | BLK | 0.69923329 |
| 80 | CSF1R | 0.69410487 |
| 81 | IRAK4 | 0.69279953 |
| 82 | TGFBR2 | 0.68993122 |
| 83 | PAK1 | 0.68263363 |
| 84 | ARAF | 0.66812417 |
| 85 | CDK6 | 0.66644458 |
| 86 | MAP3K1 | 0.65887314 |
| 87 | CSK | 0.65644999 |
| 88 | BRSK2 | 0.65538762 |
| 89 | TYK2 | 0.63623796 |
| 90 | PIM1 | 0.63545355 |
| 91 | MAP2K6 | 0.63425786 |
| 92 | IKBKB | 0.61907170 |
| 93 | AURKB | 0.61028569 |
| 94 | STK3 | 0.59257609 |
| 95 | TAOK1 | 0.57997270 |
| 96 | LATS2 | 0.57566405 |
| 97 | TEC | 0.56257680 |
| 98 | MATK | 0.53698239 |
| 99 | SYK | 0.52105408 |
| 100 | LYN | 0.49985662 |
| 101 | JAK3 | 0.49161008 |
| 102 | PRKCI | 0.44156676 |
| 103 | EPHB1 | 0.43993954 |
| 104 | VRK1 | 0.43426363 |
| 105 | GRK5 | 0.41746522 |
| 106 | PLK4 | 0.41511601 |
| 107 | STK4 | 0.40963473 |
| 108 | MAPKAPK2 | 0.40447792 |
| 109 | RIPK1 | 0.40102944 |
| 110 | IKBKE | 0.39871978 |
| 111 | MOS | 0.38603223 |
| 112 | LATS1 | 0.37787638 |
| 113 | CDK7 | 0.37458972 |
| 114 | ERBB2 | 0.37195756 |
| 115 | PDGFRA | 0.36829396 |
| 116 | KIT | 0.36570171 |
| 117 | STK38L | 0.36270603 |
| 118 | MAP4K1 | 0.35980575 |
| 119 | DYRK1B | 0.34983929 |
| 120 | MAP3K2 | 0.34729853 |
| 121 | MARK3 | 0.34634554 |
| 122 | PDPK1 | 0.34590624 |
| 123 | ZAK | 0.33430859 |
| 124 | AURKA | 0.32242437 |
| 125 | MAP3K13 | 0.31784954 |
| 126 | BTK | 0.31342223 |
| 127 | MAPKAPK5 | 0.30488132 |
| 128 | MAPK11 | 0.30462027 |
| 129 | PTK2B | 0.28600286 |
| 130 | CSNK1G3 | 0.28468332 |
| 131 | RAF1 | 0.28254811 |
| 132 | GSK3A | 0.28094339 |
| 133 | CSNK2A1 | 0.27220650 |
| 134 | CCNB1 | 0.26063114 |
| 135 | HCK | 0.25983648 |
| 136 | CAMK2G | 0.25458960 |
| 137 | ADRBK2 | 0.25118590 |
| 138 | PRKCD | 0.23992549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.99588356 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.81414529 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.72822670 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.46544381 |
| 5 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.43569805 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.38762472 |
| 7 | * Glutathione metabolism_Homo sapiens_hsa00480 | 2.35002138 |
| 8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.14647795 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07904199 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02497259 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01096778 |
| 12 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99440428 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96936283 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.82283065 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.80404378 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.78579777 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73073290 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65932857 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.64213431 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.60070705 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57896071 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56452827 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56031348 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.55452013 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55356601 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45874814 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44743487 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.43722535 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42652728 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41756466 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41120745 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.38232865 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.35883371 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35005054 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34136160 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33479665 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30527630 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27599236 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26582716 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.26027601 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.26005385 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25223014 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.23520646 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22905886 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21631623 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21011270 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19589266 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19576984 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.16982067 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16313211 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10777966 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08570454 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07320483 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07108589 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06290666 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06283557 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06177066 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05934988 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 1.05658431 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 1.04569140 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02366683 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00827050 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00162327 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99374616 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98331765 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97487070 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96928245 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96334893 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95293814 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94101954 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93946695 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93321031 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92832949 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.92425252 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90331247 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89689484 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86910437 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86540239 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85897357 |
| 80 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82758832 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.81411999 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81319205 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.80978569 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80648166 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79288275 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78840289 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78248995 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78011980 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.77901538 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.77893348 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77414623 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76175582 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73938765 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.73875389 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73536918 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73417419 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.73393948 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73138216 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73084371 |
| 100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70695601 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70652601 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70334329 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69574320 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65064632 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64277926 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62352331 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.59925434 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59806373 |
| 109 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58998765 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57128748 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56041812 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54329907 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54122523 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.53789266 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.53565429 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.53525059 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52941518 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51483954 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51393972 |
| 120 | RNA transport_Homo sapiens_hsa03013 | 0.51389083 |
| 121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50419417 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48924469 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48434186 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48223920 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47585684 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.47492287 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.47173552 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46762690 |
| 129 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43973801 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.42950447 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42587462 |
| 132 | Mismatch repair_Homo sapiens_hsa03430 | 0.42230500 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41098711 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.41026830 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40056863 |
| 136 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39142450 |

